Harbor Investment Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.4K Hold
182
﹤0.01% 658
2026
Q1
$53.3K Sell
182
-309
-63% -$102K ﹤0.01% 612
2025
Q4
$172K Buy
491
+206
+72% +$69.6K 0.01% 427
2025
Q3
$92.1K Sell
285
-55
-16% -$17.1K 0.01% 516
2025
Q2
$132K Sell
340
-9
-3% -$3.62K 0.01% 440
2025
Q1
$152K Sell
349
-1,161
-77% -$466K 0.01% 405
2024
Q4
$557K Sell
1,510
-387
-20% -$162K 0.05% 220
2024
Q3
$986K Sell
1,897
-33
-2% -$17.6K 0.1% 160
2024
Q2
$1.05M Sell
1,930
-16
-0.8% -$8.46K 0.11% 138
2024
Q1
$1.01M Sell
1,946
-60
-3% -$29.8K 0.11% 144
2023
Q4
$946K Sell
2,006
-146
-7% -$67.5K 0.11% 148
2023
Q3
$937K Buy
2,152
+132
+7% +$59.9K 0.12% 136
2023
Q2
$897K Buy
2,020
+122
+6% +$56.3K 0.13% 149
2023
Q1
$873K Buy
1,898
+382
+25% +$182K 0.13% 149
2022
Q4
$778K Sell
1,516
-158
-9% -$80.2K 0.12% 154
2022
Q3
$760K Buy
1,674
+52
+3% +$24.9K 0.13% 146
2022
Q2
$783K Sell
1,622
-2
-0.1% -$989 0.13% 148
2022
Q1
$798K Sell
1,624
-21
-1% -$9.6K 0.11% 162
2021
Q4
$763K Buy
1,645
+124
+8% +$52.2K 0.1% 174
2021
Q3
$567K Buy
1,521
+23
+2% +$8.74K 0.08% 207
2021
Q2
$572K Buy
1,498
+14
+0.9% +$5.35K 0.08% 212
2021
Q1
$533K Buy
1,484
+136
+10% +$43.7K 0.08% 200
2020
Q4
$433K Hold
1,348
0.07% 206
2020
Q3
$362K Sell
1,348
-41
-3% -$11K 0.07% 195
2020
Q2
$365K Buy
1,389
+290
+26% +$77.4K 0.08% 179
2020
Q1
$250K Buy
1,099
+628
+133% +$171K 0.07% 202
2019
Q4
$142K Buy
+471
New +$130K 0.03% 297

Other funds holding ELV

Harbor Investment Advisory's ELV Position: Q2 2026 in Review

Harbor Investment Advisory held its Elevance Health (ELV) position steady in Q2 2026 at 182 shares worth $70.4K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Harbor Investment Advisory first reported a position in ELV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.05M in Q2 2024. 466 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Harbor Investment Advisory held 182 shares of Elevance Health worth $70.4K as of Q2 2026.
  • Harbor Investment Advisory left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #658 holding.
  • Harbor Investment Advisory first reported a position in Elevance Health in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Elevance Health position peaked at $1.05M in Q2 2024.
  • 466 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.